drugset / Trial / NCT04461483
A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single Ascending Dose and Multiple Doses With Titration of TAK-935 in Healthy Japanese Participants
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of TAK-935 with single ascending doses (Part 1) and multiple doses with titration (Part 2).
Timeline
- Start
- 2020-08-13
- Primary completion
- 2020-11-14
- Completion
- 2020-11-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Soticlestat | Small molecule | 200 mg | Oral |
| Subject | Soticlestat | Small molecule | 300 mg | Oral |
| Subject | Soticlestat | Small molecule | 600 mg | Oral |
| Subject | Soticlestat | Small molecule | 1200 mg | Oral |
Indications
No indication recorded.